MH Weisman

1.3k total citations
20 papers, 876 citations indexed

About

MH Weisman is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, MH Weisman has authored 20 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 13 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in MH Weisman's work include Systemic Lupus Erythematosus Research (13 papers), T-cell and B-cell Immunology (5 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). MH Weisman is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), T-cell and B-cell Immunology (5 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). MH Weisman collaborates with scholars based in United States, Philippines and China. MH Weisman's co-authors include DJ Wallace, Mariko Ishimori, John D. Reveille, Frances M. K. Williams, Maripat Corr, Sammy Saab, Dror Berel, Meenakshi Jolly, Cynthia Aranow and Robert S. Katz and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy and Value in Health.

In The Last Decade

MH Weisman

20 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MH Weisman United States 13 656 384 141 136 118 20 876
Álvaro Danza Uruguay 10 553 0.8× 282 0.7× 85 0.6× 67 0.5× 128 1.1× 35 763
M. Pétri United States 17 850 1.3× 607 1.6× 67 0.5× 81 0.6× 210 1.8× 27 1.2k
Chryssa Papasteriades Greece 17 444 0.7× 378 1.0× 115 0.8× 157 1.2× 140 1.2× 31 918
Konstantinos Tselios Canada 20 810 1.2× 540 1.4× 58 0.4× 87 0.6× 141 1.2× 55 1.1k
Cheng Lay Teh Malaysia 12 546 0.8× 275 0.7× 66 0.5× 74 0.5× 57 0.5× 35 693
Z. Bahloul Tunisia 16 455 0.7× 256 0.7× 104 0.7× 99 0.7× 60 0.5× 140 905
Laniyati Hamijoyo Indonesia 11 640 1.0× 368 1.0× 55 0.4× 80 0.6× 187 1.6× 69 798
Christine E. Codding United States 9 613 0.9× 505 1.3× 270 1.9× 98 0.7× 114 1.0× 9 1.2k
R DEMAN Belgium 8 334 0.5× 158 0.4× 157 1.1× 103 0.8× 64 0.5× 14 913
Nathalie Morel France 17 740 1.1× 233 0.6× 234 1.7× 54 0.4× 68 0.6× 44 997

Countries citing papers authored by MH Weisman

Since Specialization
Citations

This map shows the geographic impact of MH Weisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MH Weisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MH Weisman more than expected).

Fields of papers citing papers by MH Weisman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MH Weisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MH Weisman. The network helps show where MH Weisman may publish in the future.

Co-authorship network of co-authors of MH Weisman

This figure shows the co-authorship network connecting the top 25 collaborators of MH Weisman. A scholar is included among the top collaborators of MH Weisman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MH Weisman. MH Weisman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Azizoddin, Desiree R., Richard G. Olmstead, Carrye Cost, et al.. (2017). A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus. Lupus. 26(9). 967–974. 2 indexed citations
2.
Jolly, Meenakshi, S Toloza, Berna Göker, et al.. (2017). Disease-specific quality of life in patients with lupus nephritis. Lupus. 27(2). 257–264. 42 indexed citations
3.
Rogatko, André, et al.. (2012). Prevalence of angina in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 14(S3). 2 indexed citations
4.
Agarwal, Megha, et al.. (2012). Lupus cardiomyopathy: a reversible form of left ventricular dysfunction. Arthritis Research & Therapy. 14(S3). 2 indexed citations
5.
McMahon, Maureen, Brian J. Skaggs, Lori Sahakian, et al.. (2011). High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Annals of the Rheumatic Diseases. 70(9). 1619–1624. 111 indexed citations
6.
Huang, Bin, MH Weisman, Jonathan Samuels, et al.. (2011). Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial. Pediatric Rheumatology. 9(S1). 3 indexed citations
7.
Wallace, DJ, et al.. (2011). High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus. 20(6). 588–597. 93 indexed citations
9.
Torralba, Karina D., et al.. (2010). Depression predicts self-reported disease activity in systemic lupus erythematosus. Lupus. 20(1). 80–84. 32 indexed citations
10.
Hamijoyo, Laniyati, et al.. (2010). Studies of Filipino patients with systemic lupus erythematosus: Autoantibody profile of first-degree relatives. Lupus. 20(5). 537–543. 18 indexed citations
11.
Wallace, DJ, et al.. (2009). Review: Male systemic lupus erythematosus: a review of sex disparities in this disease. Lupus. 19(2). 119–129. 133 indexed citations
13.
Ward, Marcia M., et al.. (2007). Clinical, radiographic and functional differences between juvenile-onset and adult–onset ankylosing spondylitis: results from the PSOAS cohort. Annals of the Rheumatic Diseases. 67(2). 233–237. 55 indexed citations
14.
Williams, Frances M. K., et al.. (2007). The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease. Annals of the Rheumatic Diseases. 67(5). 710–712. 149 indexed citations
15.
Weisman, MH, et al.. (2004). PES9 ELIGIBILITY, UTILIZATION, AND COSTS IN A CALIFORNIA MEDICAID LUPUS POPULATION. Value in Health. 7(3). 260–260. 3 indexed citations
16.
Iverson, G. Michael, Richard Furie, J M Cash, et al.. (2001). Pre-treatment affinity for LJP 394 influences pharmacodynamic response in lupus patients. Lupus. 10(8). 526–532. 21 indexed citations
17.
Furie, Richard, J M Cash, MaryAnne Cronin, et al.. (2001). Treatment of systemic lupus erythematosus with LJP 394.. PubMed. 28(2). 257–65. 81 indexed citations
18.
Saab, Sammy, Maripat Corr, & MH Weisman. (1998). Corticosteroids and systemic lupus erythematosus pancreatitis: a case series.. PubMed. 25(4). 801–6. 53 indexed citations
19.
Weisman, MH, et al.. (1982). Analysis of auranofin as a rheumatoid remitting agent.. PubMed. 8. 132–6. 8 indexed citations
20.
Weisman, MH, et al.. (1977). Heparin therapy-part I.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(3). 13–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026